Geoff Martha, chairman and CEO of Medtronic, updates us on Medtronic’s first-quarter performance. Martha reports the Delta variant has had an impact on revenue, but Medtronic forecasts a return to normal soon. This episode also discusses the Intersect ENT acquisition, the source of future growth and the company’s new metrics on patient safety.

Martha sees Delta impact lifting soon, talks vaccines, Intersect ENT and patient safety

The MedtronicTalks Podcast Series brings insights, observation and lessons from the leaders of the medtech industry’s single, largest leader. Episodes will center around one of Medtronic’s business units ranging from cardiac care to surgical robotics. We’ll talk with decision-makers who keep Medtronic at the forefront of Medtech. We’ll also speak with regulatory, financial and other operational leaders including the CEO about how Medtronic is preparing for the future.

Share Martha sees Delta impact lifting soon, talks vaccines, Intersect ENT and patient safety

Sign up to save your podcasts

Martha sees Delta impact lifting soon, talks vaccines, Intersect ENT and patient safety

Martha sees Delta impact lifting soon, talks vaccines, Intersect ENT and patient safety